Maxia Strategies LLC is a life sciences regulatory consultancy. We specialize in creating efficient product development strategies and providing supporting regulatory services. Our primary focus is helping small to medium-sized enterprises maximize the value of their products throughout their development lifecycle.
In the fast-changing life sciences space, knowledge and experience are critical success factors. When combined with independent thinking, they provide truly actionable insights – opportunities arise, problems dissolve and solutions appear. At Maxia Strategies, we help you define your core development strategies and implement operational solutions to achieve them.
Strategic Regulatory Support
Regulatory strategy integrates corporate governance, quality management and product development. From ‘virtual’ start-up to established biotech, we help our clients develop effective strategies aligned with the company’s and product’s lifecycle.
Dynamic Regulatory Environment
While an effective strategy provides a consistent framework to support development, it must also evolve with the highly dynamic regulatory environment in which we operate. We constantly monitor regulatory developments and help our clients foresee and exploit new opportunities.
Unique Development Programs
We recognize that every development program is unique. We approach each project with an open mind and thoroughly explore how all the nuances may impact the development options. Then we identify optimal solutions to meet the needs of our partners, their products and their patients.
Regulatory Communication and Compliance
In our highly digital world, regulatory communication and compliance is becoming increasingly complex and critical. We help companies meet their commitments while maintaining flexibility. We also work with your in-house staff and/or CRO of choice to ensure accurate submissions and maintain critical timelines.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Grellingerstrasse 9, Basel,basel-Stadt 4052,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- maxiastrategies.com
- Keywords
- Health Authority Interactions, Quality Management Systems, Orphan Disease Designation, Pediatric Investigation Plans, Strategic Regulatory Support, Regulatory Communication, Document Management, Investigator Brochures, Clinical Study Reports, Dossier Compilation and Submission, Risk Management Plans, Annual Reporting Compliance, Accelerated Pathways, SME Representation at EMA, Due Diligence Support for In/Out-Licensing, Global Synchronization.
- HQ
- Basel, Basel-Stadt
Maxia Strategies Llc Questions
Maxia Strategies Llc's website is maxiastrategies.com
Maxia Strategies Llc's LinkedIn profile is https://ch.linkedin.com/company/maxia-strategies-llc
Maxia Strategies Llc has
4 employees.
View email and phone details for 4
employees at Maxia Strategies Llc.
Maxia Strategies Llc's industry is
Pharmaceutical Manufacturing
Maxia Strategies Llc's top competitors are
Pracipio Ltd,
Ewopharma,
Adryan,
Digehealth,
Stiftung Idéesport,
Sobi - Swedish Orphan Biovitrum Ab (Publ),
Alltimm Gmbh,
Implanz,
Mugenbio,
Neosens.
Maxia Strategies Llc's categories are Pharmaceutical Manufacturing
Maxia Strategies Llc's founding year is 2010
